These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 10502816)

  • 1. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.
    Heymans S; Luttun A; Nuyens D; Theilmeier G; Creemers E; Moons L; Dyspersin GD; Cleutjens JP; Shipley M; Angellilo A; Levi M; Nübe O; Baker A; Keshet E; Lupu F; Herbert JM; Smits JF; Shapiro SD; Baes M; Borgers M; Collen D; Daemen MJ; Carmeliet P
    Nat Med; 1999 Oct; 5(10):1135-42. PubMed ID: 10502816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory pathways and cardiac repair: the affliction of infarction.
    Knowlton KU; Chien KR
    Nat Med; 1999 Oct; 5(10):1122-3. PubMed ID: 10502807
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
    Tsujita K; Kaikita K; Hayasaki T; Honda T; Kobayashi H; Sakashita N; Suzuki H; Kodama T; Ogawa H; Takeya M
    Circulation; 2007 Apr; 115(14):1904-11. PubMed ID: 17389263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.
    Heymans S; Lupu F; Terclavers S; Vanwetswinkel B; Herbert JM; Baker A; Collen D; Carmeliet P; Moons L
    Am J Pathol; 2005 Jan; 166(1):15-25. PubMed ID: 15631996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for white blood cell NAD(P)H oxidase-mediated plasminogen activator inhibitor-1 oxidation and ventricular rupture following acute myocardial infarction.
    Agarwal U; Zhou X; Weber K; Dadabayev AR; Penn MS
    J Mol Cell Cardiol; 2011 Mar; 50(3):426-32. PubMed ID: 20807543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency in TIMP-3 increases cardiac rupture and mortality post-myocardial infarction via EGFR signaling: beneficial effects of cetuximab.
    Hammoud L; Lu X; Lei M; Feng Q
    Basic Res Cardiol; 2011 May; 106(3):459-71. PubMed ID: 21243368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
    Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
    González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
    Moriwaki H; Stempien-Otero A; Kremen M; Cozen AE; Dichek DA
    Circ Res; 2004 Sep; 95(6):637-44. PubMed ID: 15297377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
    Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
    J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
    Angoulvant D; Fazel S; Weisel RD; Lai TY; Fedak PW; Chen L; Rafati S; Seneviratne CK; Degousee N; Li RK
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):471-80. PubMed ID: 19185172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the fibrinolytic system in corneal angiogenesis.
    Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
    Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia.
    Chang DI; Hosomi N; Lucero J; Heo JH; Abumiya T; Mazar AP; del Zoppo GJ
    J Cereb Blood Flow Metab; 2003 Dec; 23(12):1408-19. PubMed ID: 14663336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy.
    Schroen B; Heymans S; Sharma U; Blankesteijn WM; Pokharel S; Cleutjens JP; Porter JG; Evelo CT; Duisters R; van Leeuwen RE; Janssen BJ; Debets JJ; Smits JF; Daemen MJ; Crijns HJ; Bornstein P; Pinto YM
    Circ Res; 2004 Sep; 95(5):515-22. PubMed ID: 15284191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
    Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
    J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor.
    Prager GW; Breuss JM; Steurer S; Olcaydu D; Mihaly J; Brunner PM; Stockinger H; Binder BR
    Circ Res; 2004 Jun; 94(12):1562-70. PubMed ID: 15131009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: a potential role in connective tissue destruction.
    Bodet C; Andrian E; Tanabe S; Grenier D
    J Cell Physiol; 2007 Jul; 212(1):189-94. PubMed ID: 17299802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
    Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
    Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.